CSC
DARE icon

Caldwell Sutter Capital’s Dare Bioscience DARE Stock Holding History

Caldwell Sutter Capital’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31 Hold
17
– – ﹤0.01% 876
2025
Q4 		$33 Hold
17
– – ﹤0.01% 863
2025
Q3 		$36 Hold
17
– – ﹤0.01% 856
2025
Q2 		$41 Hold
17
– – ﹤0.01% 839
2025
Q1 		$49 Hold
17
– – ﹤0.01% 873
2024
Q4 		$53 Hold
17
– – ﹤0.01% 880
2024
Q3 		$55 Hold
17
– – ﹤0.01% 890
2024
Q2 		$67 Hold
17
– – ﹤0.01% 901
2024
Q1 		$98 Hold
17
– – ﹤0.01% 896
2023
Q4 		$62 Hold
17
– – ﹤0.01% 937
2023
Q3 		$92 Hold
17
– – ﹤0.01% 866
2023
Q2 		$182 Buy
+17
New +$202 ﹤0.01% 843

Other funds holding DARE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Caldwell Sutter Capital's DARE Position: Q1 2026 in Review

Caldwell Sutter Capital held its Dare Bioscience (DARE) position steady in Q1 2026 at 17 shares worth $31. The position accounts for ﹤0.01% of the portfolio, ranked #876.

Caldwell Sutter Capital first reported a position in DARE in Q2 2023 and has held it in 12 quarters since. The position peaked at $182 in Q2 2023. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.

  • Caldwell Sutter Capital held 17 shares of Dare Bioscience worth $31 as of Q1 2026.
  • Caldwell Sutter Capital left its Dare Bioscience share count unchanged in Q1 2026.
  • Dare Bioscience made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q1 2026, its #876 holding.
  • Caldwell Sutter Capital first reported a position in Dare Bioscience in Q2 2023 and has held it in 12 quarters since.
  • Caldwell Sutter Capital's Dare Bioscience position peaked at $182 in Q2 2023.
  • 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.

Based on Caldwell Sutter Capital's 13F filing for Q1 2026, filed 6 May 2026.